We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Exhibits New Lab Solutions in Dubai

By LabMedica International staff writers
Posted on 08 Feb 2017
Beckman Coulter, Inc., an international leader in developing clinical diagnostic products and solutions, exhibited its laboratory solutions, including its DxN VERIS molecular diagnostics system and DxH 500 hematology system, at MEDLAB 2017.

The company’s DxN VERIS molecular diagnostics system aims to revolutionize laboratory workflow by delivering greater productivity and increased flexibility to laboratories, ensuring that results are available to physicians as quickly as possible, for faster clinical decision-making and positively impacting the patient pathway.

Beckman Coulter’s DxH 500 hematology system is the first of a new series of advanced hematology analyzers specifically designed for laboratories with low-volume hematology workloads. More...
With its small sample volume requirements, intuitive software and low reagent consumption, the advanced 5-part differential system aims to simplify the workload in a low-volume lab.

Also on display at the 4-day event held from February 6-9, 2017, in Dubai, UAE, was Beckman Coulter’s DxH Connected Workcells solution for in vitro diagnostic use. In addition to reducing manual work with accurate first-pass results and processing specimens faster with customizable workflow solutions for labs, it delivers reliable results from difficult specimens and also simplifies autovalidation with comprehensive data management.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Dopamine Assay
Dopamine ELISA Kit
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.